Matthew Henn – Biography
Last update: 15 days agoExecutive profile
Matthew Henn joined Seres Therapeutics in 2012. Matthew served as Senior Vice President, Head of Drug Discovery & Bioinformatics and Executive Vice President, Microbiome Research & Development for Seres Therapeutics.
Matthew Henn is currentlyExecutive Vice President and Chief Scientific Officer at Seres Therapeutics - View - Seres Therapeutics org chart
Create your alert
to follow the career of Matthew Henn.
Education
Matthew Henn has a Bachelor of Science in Ecology & Evolutionary Biology from University of New Hampshire in 1997 and a Doctor of Philosophy in Microbiology and Ecosystem Sciences from University of California, Berkeley in 2002.
They have also studied at University of New Hampshire :
Find more alumni from University of New Hampshire
They have also studied at University of California, Berkeley :
Find more alumni from University of California, Berkeley
More about Matthew Henn
Selected links
Do you need to know more about Matthew Henn? More results.
Participate
Social media
- Matthew Henn on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Matthew Henn
The colleagues of Matthew Henn
Company Colleagues
- At Seres Therapeutics, Matthew Henn has 23 colleagues including Richard Kender (Chairman & Interim CEO), Stephen Berenson (Director)…
Homonyms
- Matthew Henninger - Director - Abundia Global Impact Group
Industry Colleagues
- In the Biotechnology industry, Matthew Henn has 35,753 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Matthew Henn.
Get in Touch
Here are a few tips for establishing great contacts.
